In addition, we found no statistically significant differences between one-year non-surviving and surviving patients in ABO blood type, Child–Pugh score, degree of tumor differentiation, sex, infiltration, inside Milan criteria before and after LT, macrovascular invasion, microvascular invasion, multinodular tumor, portal hypertension, LT technique, pre-LT treatment, age of LT recipient, model for end-stage liver disease (MELD) score, serum AFP levels, and nodule size. The gene discussed is AFP; the disease is neoplasm.